Daijiworld Media Network – Washington

Washington, Sep 24: New federal data show a sharp jump in infections caused by a dangerous, multidrug-resistant bacterium across the United States, raising fresh concerns over treatment options and patient safety.

A review of the Centers for Disease Control and Prevention’s (CDC) Antimicrobial Resistance (AR) Laboratory Network data reveals that the age-adjusted incidence of carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) climbed 69% between 2019 and 2023. CRE includes carbapenem-resistant strains of Escherichia coli, Klebsiella pneumoniae and Enterobacter—pathogens notorious for causing hard-to-treat hospital infections.

Researchers found that infections carrying the New Delhi metallo-beta-lactamase (NDM) gene surged by an a

See Full Page